Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Cage Bio Inc.

Home Clinical Trial Sponsors and OrganizationsCage Bio Inc.

Cage Bio Inc.

733 Indtl Rd, San Carlos, California, United States

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

10

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

40.0%

Phase 2

3

30.0%

Early Phase 1

1

10.0%

Not Applicable

1

10.0%

Trial Status Distribution

Completed

6

60.0%

Not yet recruiting

1

10.0%

Recruiting

2

20.0%

Unknown

1

10.0%

Clinical Trials

Trials sponsored by this organization (10)

A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo

Jul 202536 participants

A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis

Not yet recruiting

Apr 20253 participants

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Dec 2024180 participants

Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis

Nov 202240 participants

An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection

Feb 202215 participants

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea

May 202178 participants

Clinical Evaluation of the Residual Antimicrobial Activity

Jun 202012 participants

CGB-400 for the Reduction of Facial Redness

Oct 201825 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials10
Approvals
News

Back to Organizations